Xerophthalmia

Xerophthalmia is an ophthalmologic condition characterized by pathological dryness of the ocular surface, encompassing the conjunctiva and cornea, that results primarily from vitamin A deficiency. The term derives from the Greek words xeros, meaning dry, and ophthalmos, meaning eye. While the condition is well-documented in human medicine, particularly in developing countries with widespread nutritional deficiencies, xerophthalmia also occurs in dogs and can lead to significant ocular morbidity if not recognized and treated promptly.

Vitamin A plays a critical role in maintaining the health and integrity of epithelial tissues throughout the body, including the specialized epithelium of the ocular surface. The conjunctival and corneal epithelium depend on adequate vitamin A for normal differentiation, mucin production, and maintenance of the tear film. When vitamin A levels become deficient, these epithelial surfaces undergo a process called squamous metaplasia, in which the normal mucin-secreting goblet cells are replaced by keratinized squamous cells. This transformation fundamentally disrupts the tear film, leading to progressive drying of the ocular surface.

In dogs, xerophthalmia is less common than in some other species because most commercially formulated dog foods contain adequate levels of vitamin A. However, the condition can develop in dogs fed severely imbalanced homemade diets, dogs with malabsorptive gastrointestinal conditions that impair vitamin A absorption, dogs with hepatic disease that disrupts vitamin A metabolism and storage, and in rare cases, dogs with genetic conditions affecting vitamin A transport or utilization. The condition may also develop secondarily when chronic illness reduces appetite and overall nutritional intake.

The clinical significance of xerophthalmia extends beyond the immediate ocular symptoms. Vitamin A deficiency that is severe enough to produce ocular manifestations typically indicates a systemic nutritional deficiency that may be affecting multiple organ systems. The skin, respiratory epithelium, gastrointestinal epithelium, and immune system all depend on vitamin A for normal function, and deficiency can produce widespread pathological changes. Therefore, the recognition of xerophthalmia should prompt a comprehensive evaluation of the dog's nutritional status and overall health.

The primary cause of xerophthalmia is inadequate vitamin A availability, which can result from insufficient dietary intake, impaired absorption from the gastrointestinal tract, defective hepatic storage or metabolism, or increased physiological demand that outstrips supply. Understanding the various pathways that can lead to vitamin A deficiency is essential for identifying at-risk dogs and implementing appropriate preventive or therapeutic measures.

Dietary deficiency remains the most straightforward cause of xerophthalmia in dogs. Dogs that are fed exclusively on homemade diets formulated without veterinary nutritional guidance are at particular risk, as these diets may lack adequate sources of preformed vitamin A (retinol) or provitamin A carotenoids. Unlike some other species, dogs have limited ability to convert beta-carotene to retinol, making preformed vitamin A from animal sources such as liver, fish oils, and egg yolks particularly important in the canine diet. Dogs fed on table scraps, dogs in situations of neglect where food availability is inconsistent, and dogs maintained on restrictive or elimination diets for prolonged periods without appropriate supplementation may also develop deficiency.

Gastrointestinal conditions that impair fat absorption can lead to vitamin A deficiency because vitamin A is a fat-soluble vitamin that requires adequate dietary fat and functional fat absorption mechanisms for proper uptake from the intestinal lumen. Conditions such as exocrine pancreatic insufficiency, inflammatory bowel disease, lymphangiectasia, and chronic enteritis can all compromise vitamin A absorption even when dietary intake is adequate. Surgical resection of significant portions of the small intestine can similarly reduce absorptive capacity for fat-soluble vitamins.

Hepatic disease represents another important pathway to vitamin A deficiency and xerophthalmia. The liver serves as the primary storage organ for vitamin A in the body and is responsible for converting absorbed retinol esters to the active forms of the vitamin, including retinal and retinoic acid. Chronic hepatic diseases such as portosystemic shunts, chronic hepatitis, cirrhosis, and hepatic lipidosis can impair vitamin A storage, metabolism, and release, leading to functional deficiency even when dietary intake and intestinal absorption are normal.

In some cases, increased demand for vitamin A during periods of rapid growth, pregnancy, lactation, or concurrent illness can deplete reserves and precipitate deficiency. Puppies from large litters receiving inadequate maternal nutrition may be born with limited vitamin A stores, and if weaned onto an inadequate diet, can develop deficiency manifestations at an early age. Additionally, certain medications and toxins can interfere with vitamin A metabolism or accelerate its depletion, and concurrent zinc deficiency can impair the mobilization of vitamin A from hepatic stores because zinc is required for the synthesis of retinol-binding protein.

The clinical manifestations of xerophthalmia in dogs develop progressively as vitamin A deficiency worsens, with ocular signs typically accompanied by systemic manifestations reflecting the widespread importance of vitamin A in maintaining epithelial integrity and immune function. Early recognition of the characteristic signs allows for timely intervention and can prevent the progression to irreversible ocular damage.

The earliest ocular sign of xerophthalmia is typically conjunctival xerosis, characterized by a dry, lusterless appearance of the conjunctival membranes. The normally moist, glistening conjunctiva becomes dull and thickened, and the conjunctival blood vessels may become more prominent as the mucous membrane loses its normal transparency. Affected dogs may show increased blinking frequency, mild ocular discharge that is initially mucoid in character, and subtle signs of ocular discomfort such as squinting or rubbing at the eyes.

As the condition progresses, corneal involvement becomes apparent. The cornea, which depends on an intact tear film and healthy epithelium for its clarity, begins to show signs of drying and keratinization. The corneal surface may develop a hazy, roughened appearance, and punctate epithelial erosions may appear across the corneal surface. These epithelial defects predispose the cornea to secondary bacterial infection, which can lead to corneal ulceration. In severe cases, progressive corneal opacification develops as the corneal epithelium undergoes squamous metaplasia and loses its normal stratified structure.

Systemic manifestations of vitamin A deficiency often accompany or precede the ocular signs and may provide important diagnostic clues. The skin may develop a dry, flaky quality with increased seborrheic changes, and the coat may appear dull and rough. Hyperkeratosis of the footpads may be observed. Dogs with significant vitamin A deficiency may show increased susceptibility to infections due to impaired immune function, particularly affecting the respiratory and gastrointestinal tracts. Growth retardation may be apparent in puppies and young dogs. Reproductive abnormalities, including infertility and fetal resorption, can occur in breeding animals with chronic deficiency.

In the most severe and advanced cases of xerophthalmia, keratomalacia may develop, which represents liquefactive necrosis of the cornea. This devastating complication can lead to corneal perforation, endophthalmitis, and irreversible blindness. While keratomalacia is exceedingly rare in dogs in developed countries where veterinary care is accessible, it underscores the importance of early recognition and treatment of vitamin A deficiency before irreversible ocular damage occurs.

Diagnosing xerophthalmia requires a combination of clinical examination findings, assessment of vitamin A status through laboratory testing, and identification of the underlying cause of deficiency. A systematic diagnostic approach is essential because the ocular manifestations of xerophthalmia can overlap with other causes of ocular surface disease, and accurate diagnosis is necessary to guide appropriate treatment.

The ophthalmic examination provides critical information for recognizing xerophthalmia. A thorough examination should include assessment of the tear film using the Schirmer tear test, which measures aqueous tear production, and tear film break-up time, which evaluates tear film stability. In xerophthalmia, the Schirmer tear test results may be normal or mildly reduced because the primary deficit is in the mucin layer of the tear film rather than the aqueous component. However, tear film break-up time is typically shortened due to the loss of mucin-producing goblet cells. Fluorescein staining of the cornea can reveal punctate epithelial erosions, corneal ulceration, or other epithelial defects. Rose bengal staining, which highlights devitalized and desquamated epithelial cells, may demonstrate widespread ocular surface damage.

Laboratory assessment of vitamin A status is important for confirming the diagnosis. Serum retinol levels can be measured and, when significantly depressed, support a diagnosis of vitamin A deficiency. However, serum retinol is under homeostatic regulation and may remain within the normal range until hepatic reserves are nearly exhausted, making a single normal serum retinol level insufficient to exclude deficiency. Retinol-binding protein levels and the retinol-to-retinol-binding protein ratio can provide additional information about functional vitamin A status. In some cases, hepatic vitamin A levels obtained through liver biopsy provide the most accurate assessment of total body vitamin A stores, though this invasive procedure is rarely necessary for clinical diagnosis.

Conjunctival impression cytology is a valuable diagnostic tool that can provide direct evidence of the epithelial changes characteristic of xerophthalmia. This technique involves pressing a small piece of filter paper or cellulose acetate against the conjunctival surface to collect superficial epithelial cells, which are then stained and examined microscopically. In xerophthalmia, impression cytology reveals a loss of goblet cells, squamous metaplasia of the conjunctival epithelium, and an increase in keratinized cells. These cytological findings can be present before clinical signs become overt, making impression cytology a potentially useful screening tool in at-risk populations.

A comprehensive diagnostic workup should also include evaluation for underlying conditions that may have led to vitamin A deficiency. This may include a detailed dietary history, complete blood count, serum biochemistry profile with emphasis on hepatic parameters, fecal analysis for evidence of malabsorption, and potentially gastrointestinal imaging or endoscopy if malabsorptive disease is suspected. Identifying and addressing the underlying cause is as important as treating the deficiency itself, because vitamin A supplementation alone will not produce sustained improvement if ongoing malabsorption or hepatic dysfunction continues to deplete vitamin A stores.

Treatment of xerophthalmia in dogs requires a dual approach that addresses both the immediate ocular pathology and the underlying vitamin A deficiency. The urgency and intensity of treatment depend on the severity of the ocular and systemic manifestations, with more advanced cases requiring more aggressive intervention to prevent irreversible ocular damage.

Vitamin A supplementation is the cornerstone of treatment for xerophthalmia caused by nutritional deficiency. The route, dose, and duration of supplementation depend on the severity of the deficiency and the presence of any underlying conditions that may affect absorption. For dogs with functional gastrointestinal tracts, oral supplementation with retinyl palmitate or retinyl acetate is typically effective. Initial loading doses may be administered to rapidly replenish depleted hepatic stores, followed by a maintenance dose that is gradually reduced as the deficiency resolves. In cases where gastrointestinal malabsorption is present, parenteral administration of vitamin A may be necessary to bypass the absorptive defect.

It is critically important that vitamin A supplementation be performed under veterinary supervision because vitamin A is a fat-soluble vitamin that can accumulate in the body, and excessive supplementation can lead to hypervitaminosis A, a condition that is itself associated with serious health consequences. Signs of vitamin A toxicity include skeletal abnormalities, hepatic damage, and skin changes. The therapeutic window between doses that correct deficiency and doses that produce toxicity must be carefully navigated, particularly in smaller dogs where the margin is narrower.

Topical ophthalmic treatment is essential for managing the ocular manifestations of xerophthalmia while systemic vitamin A supplementation takes effect. Artificial tear preparations, particularly those containing hyaluronic acid or carboxymethylcellulose, help protect the ocular surface and prevent further desiccation damage. Topical vitamin A preparations in the form of retinol or retinyl palmitate ointment can promote healing of the conjunctival and corneal epithelium directly. If corneal ulceration is present, topical antibiotic therapy is indicated to prevent or treat secondary bacterial infection, and atropine may be used to manage ciliary spasm and pain.

Dietary correction is an essential component of treatment that must accompany supplementation to prevent recurrence. The dog's diet should be evaluated by a veterinarian or veterinary nutritionist and reformulated to provide adequate levels of vitamin A from appropriate sources. For dogs previously fed imbalanced homemade diets, transitioning to a nutritionally complete commercial diet or a properly formulated homemade diet with veterinary guidance is recommended. If an underlying condition such as exocrine pancreatic insufficiency or inflammatory bowel disease is identified as the cause of malabsorption, specific treatment for that condition must be instituted concurrently to ensure that vitamin A can be properly absorbed from the dietary and supplemental sources.

Corneal involvement in xerophthalmia represents the most vision-threatening aspect of the condition and requires particularly careful monitoring and management. The cornea is exquisitely sensitive to disruptions of the tear film and epithelial integrity, and the progressive nature of xerophthalmia means that without timely intervention, corneal complications can advance rapidly from superficial epithelial changes to full-thickness damage that threatens the structural integrity of the globe.

The spectrum of corneal complications in xerophthalmia ranges from mild punctate epithelial keratopathy to severe keratomalacia with corneal perforation. Punctate epithelial keratopathy, characterized by scattered small defects in the corneal epithelium visible with fluorescein staining, represents the earliest stage of corneal involvement and is typically reversible with appropriate treatment. As the condition progresses, larger areas of epithelial loss develop, and the underlying corneal stroma becomes exposed to the external environment, predisposing to bacterial colonization and infection.

Corneal ulceration in the context of xerophthalmia can be particularly challenging to manage because the underlying epithelial dysfunction impairs the normal wound healing response. The loss of goblet cells and disrupted tear film means that the corneal surface lacks the protective and nutritive environment necessary for efficient epithelial migration and wound closure. Superficial corneal ulcers may fail to heal or may progress to deeper stromal involvement despite appropriate antibiotic therapy. In these cases, adjunctive treatments such as autologous serum eye drops, which provide growth factors and nutrients that support epithelial healing, or application of tissue adhesives or bandage contact lenses may be necessary.

In severe cases where deep corneal ulceration threatens perforation or where perforation has already occurred, surgical intervention may be required to preserve the globe and, if possible, vision. Conjunctival pedicle grafts, corneoscleral transposition, and corneal transplantation are surgical techniques that may be employed depending on the extent and location of the corneal damage. These procedures are technically demanding and are typically performed by veterinary ophthalmologists with specialized training and equipment. The prognosis for visual function following surgical repair depends heavily on the extent of corneal damage, the success of the surgical procedure, and the patient's response to concurrent vitamin A supplementation.

Long-term monitoring of corneal health is essential for dogs recovering from xerophthalmia-associated corneal complications. Even after vitamin A levels have been normalized and active corneal disease has resolved, the cornea may retain scars or opacities from previous ulceration that can permanently affect vision. Regular ophthalmic examinations should continue for several months after clinical resolution to ensure that the ocular surface remains stable and that no new corneal lesions develop. Dogs that have experienced significant corneal damage may benefit from long-term use of artificial tear supplements to provide ongoing protection to a corneal surface that may remain vulnerable.

Xerophthalmia must be carefully differentiated from keratoconjunctivitis sicca, commonly known as dry eye or KCS, because while the two conditions share overlapping clinical features, their underlying causes, treatment approaches, and prognoses differ significantly. Accurate differentiation is essential for implementing the correct treatment strategy and avoiding mismanagement that could lead to unnecessary treatment or missed opportunities for intervention.

Keratoconjunctivitis sicca is a far more common cause of dry eye in dogs than xerophthalmia and results from inadequate aqueous tear production by the lacrimal glands. The most frequent cause of KCS in dogs is immune-mediated destruction of the lacrimal gland tissue, although it can also result from drug toxicity, neurological dysfunction, congenital alacrima, or surgical removal of the third eyelid gland. Unlike xerophthalmia, KCS is not caused by vitamin A deficiency and is not associated with nutritional status.

The clinical presentations of xerophthalmia and KCS can appear similar, with both conditions producing ocular surface drying, mucoid to mucopurulent discharge, corneal vascularization and opacification, and discomfort. However, several distinguishing features can help differentiate the two conditions. The Schirmer tear test is the most important differentiating diagnostic tool. In KCS, Schirmer values are typically significantly reduced, often below ten millimeters per minute and frequently below five millimeters per minute. In xerophthalmia, Schirmer values may be normal or only mildly reduced because aqueous tear production is not the primary deficit. Instead, the tear film instability in xerophthalmia results from the loss of mucin-producing goblet cells.

The systemic context provides additional differentiating information. Dogs with xerophthalmia typically show concurrent signs of vitamin A deficiency in other organ systems, such as dermatological changes, growth retardation, or evidence of underlying malabsorptive or hepatic disease. Dogs with KCS may have concurrent conditions associated with immune-mediated disease, such as hypothyroidism or other autoimmune disorders, but do not typically show signs of nutritional deficiency. A thorough dietary history is invaluable in this differentiation, as dogs with xerophthalmia are almost invariably found to have a history of nutritionally deficient diet or a medical condition affecting nutrient absorption.

Treatment approaches for the two conditions differ fundamentally. KCS is primarily managed with topical immunosuppressive agents, most commonly cyclosporine or tacrolimus ophthalmic preparations, which suppress the immune-mediated destruction of the lacrimal glands and can restore tear production in many cases. These medications are not effective for xerophthalmia, which requires systemic vitamin A supplementation and dietary correction. Conversely, vitamin A supplementation will not improve KCS caused by immune-mediated lacrimal gland damage. Misdiagnosis of xerophthalmia as KCS could lead to prolonged, ineffective treatment with immunosuppressive agents while the underlying vitamin A deficiency continues to worsen, potentially resulting in severe and irreversible ocular damage.

Preventing xerophthalmia in dogs is primarily a matter of ensuring adequate vitamin A nutrition throughout the animal's life, from the prenatal period through old age. With appropriate nutritional management, xerophthalmia is an entirely preventable condition, and awareness of the dietary requirements for vitamin A can help owners, breeders, and veterinary professionals eliminate this cause of ocular morbidity.

Commercially formulated dog foods that meet the nutritional standards established by the Association of American Feed Control Officials provide adequate levels of vitamin A for healthy dogs at all life stages. These standards specify minimum and maximum levels of vitamin A per kilogram of diet, ensuring that dogs consuming these foods receive sufficient vitamin A without risk of excess. Owners feeding a complete and balanced commercial diet generally need not be concerned about vitamin A deficiency, and additional supplementation is not recommended unless specifically prescribed by a veterinarian for a documented medical reason.

The risk of xerophthalmia is greatest in dogs whose diets deviate significantly from established nutritional standards. Dogs fed exclusively on homemade diets that have not been formulated by a veterinary nutritionist are at particular risk, especially if the diet consists primarily of muscle meat, rice, and a limited variety of vegetables without any organ meat or supplementation. Organ meats, particularly liver, are the richest natural sources of preformed vitamin A for dogs, and their inclusion in homemade diets, in appropriate quantities, can help prevent deficiency. However, because liver is extremely high in vitamin A, excessive inclusion can lead to toxicity, underscoring the importance of professional nutritional guidance when formulating homemade diets.

For dogs with medical conditions that predispose to vitamin A deficiency, including gastrointestinal malabsorptive disorders and hepatic disease, proactive monitoring of vitamin A status can help prevent xerophthalmia from developing. Periodic measurement of serum retinol levels in at-risk dogs allows veterinarians to identify declining vitamin A status before clinical signs emerge and to institute supplementation before ocular or systemic manifestations develop. Dogs on long-term medications known to interfere with vitamin A metabolism should similarly be monitored.

Education of dog owners about the importance of balanced nutrition represents the most effective public health approach to preventing xerophthalmia. Veterinary professionals should discuss nutritional requirements during routine wellness visits, particularly with owners who express interest in preparing homemade diets. The growing popularity of raw and homemade feeding practices makes this educational effort increasingly important, as well-intentioned owners may inadvertently create nutritionally deficient diets that place their dogs at risk for conditions like xerophthalmia. Clear, non-judgmental communication about the nutritional needs of dogs and the potential consequences of dietary imbalances can help ensure that all dogs receive the nutrition they need for ocular and overall health.

The prognosis for dogs diagnosed with xerophthalmia depends primarily on the severity of the condition at the time of diagnosis, the promptness and adequacy of treatment, and whether the underlying cause of vitamin A deficiency can be successfully addressed. When recognized early and treated appropriately, xerophthalmia carries a favorable prognosis, with most dogs achieving complete resolution of both ocular and systemic manifestations.

Dogs diagnosed in the early stages of xerophthalmia, when ocular changes are limited to conjunctival xerosis and mild epithelial irregularity without significant corneal ulceration, typically respond well to vitamin A supplementation and dietary correction. Improvement in ocular surface health can often be observed within two to four weeks of initiating treatment, with restoration of normal goblet cell populations and tear film stability occurring over a period of several weeks to a few months. Complete resolution of ocular signs is expected in the majority of these cases, with no lasting impact on vision.

The prognosis becomes more guarded when corneal complications have developed. Dogs with superficial corneal ulceration that responds to treatment with vitamin A supplementation, topical medications, and tear supplementation generally retain good vision, though some degree of corneal scarring may persist. More severe corneal disease, including deep stromal ulceration and keratomalacia, carries a more uncertain prognosis for vision. Even with aggressive treatment, eyes that have experienced significant corneal damage may develop permanent scarring, vascularization, or pigmentation that impairs visual acuity. In the most severe cases, corneal perforation and endophthalmitis may necessitate enucleation of the affected eye.

The long-term outlook for dogs that have recovered from xerophthalmia depends largely on whether the underlying cause of vitamin A deficiency has been definitively addressed. Dogs whose deficiency resulted from a correctable dietary imbalance have an excellent long-term prognosis once their diet has been appropriately reformulated, as recurrence is unlikely if adequate nutrition is maintained. Dogs with chronic underlying conditions such as inflammatory bowel disease, exocrine pancreatic insufficiency, or hepatic disease may require ongoing vitamin A supplementation and monitoring to prevent recurrence, and their long-term prognosis is influenced by the management of the primary condition.

Follow-up monitoring is important for all dogs that have been treated for xerophthalmia. Serum vitamin A levels should be checked periodically during and after the supplementation period to ensure that adequate levels have been achieved and maintained. Ophthalmic examinations should continue at regular intervals to monitor the ocular surface and detect any early signs of recurrence. Owners should be educated about the signs of vitamin A deficiency so that they can alert their veterinarian promptly if any symptoms reappear. With appropriate ongoing management and vigilance, most dogs that have recovered from xerophthalmia can enjoy a normal quality of life with preserved visual function.

While general practice veterinarians can diagnose and initiate treatment for many cases of xerophthalmia, certain situations warrant referral to a board-certified veterinary ophthalmologist for specialized evaluation and management. Understanding when referral is appropriate helps ensure that dogs with more complex or severe presentations receive the expert care needed to preserve their vision and ocular health.

Referral to a veterinary ophthalmologist should be strongly considered when corneal ulceration is present and fails to respond to initial treatment within a reasonable timeframe, typically one to two weeks. Non-healing corneal ulcers in the context of xerophthalmia may require specialized diagnostic techniques, such as corneal cytology and culture, to identify secondary infections or to assess the degree of epithelial dysfunction. The ophthalmologist can also determine whether surgical intervention, such as a conjunctival graft or other corneal surgical procedure, is necessary to promote healing and preserve corneal integrity.

Deep or rapidly progressing corneal ulceration represents a more urgent indication for ophthalmologic referral. Descemetoceles, in which the corneal stroma has been lost down to the thin Descemet's membrane, and frank corneal perforations are ophthalmologic emergencies that require immediate specialist attention. These conditions demand surgical repair to prevent loss of the globe and, when possible, to restore or preserve some degree of visual function. The specialized equipment, surgical expertise, and postoperative monitoring capabilities available in ophthalmology practices are essential for managing these complex cases.

Dogs that present with bilateral severe ocular involvement or those whose ocular disease is accompanied by signs suggesting additional ophthalmologic pathology should also be referred for specialist evaluation. Xerophthalmia can co-exist with other ocular conditions, and a comprehensive ophthalmic examination including slit-lamp biomicroscopy, tonometry, funduscopy, and potentially ocular ultrasonography can identify concurrent pathology that may influence the treatment plan and prognosis.

Any case where the diagnosis of xerophthalmia is uncertain should be evaluated by an ophthalmologist. The differential diagnosis for ocular surface disease in dogs is broad and includes conditions such as keratoconjunctivitis sicca, allergic conjunctivitis, viral or bacterial keratoconjunctivitis, and immune-mediated keratitis, each of which requires a different therapeutic approach. Misdiagnosis can lead to inappropriate treatment that may worsen the condition or delay effective therapy. A veterinary ophthalmologist can perform the specialized diagnostic tests needed to confirm or rule out xerophthalmia and to differentiate it from other conditions with similar presentations.

Finally, owners who are seeking the most comprehensive evaluation and treatment plan for their dog's ocular condition may benefit from ophthalmologic referral regardless of the severity of the presentation. Veterinary ophthalmologists can provide detailed prognostic information, develop customized treatment protocols, and offer follow-up monitoring that ensures the best possible outcome. Many general practitioners maintain referral relationships with veterinary ophthalmologists and can facilitate a smooth transition of care when specialized evaluation is indicated.